Hims & Hers Health, INC Form 4 insider transactions

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 29,277 shares of common stock on September 22, 2026 for $29.95 per share.

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 12,313 shares of common stock on September 17, 2026 for $28.82 per share.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 6,236 shares of common stock on September 16, 2026 for $27.86 per share.

Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc., sold 14,027 shares of common stock on September 15, 2026 for $28.39 per share.

Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., sold 7,954 shares of common stock on September 15, 2026 for $28.39 per share.

Andrew Dudum, Chief Executive Officer, a Director and 10% owner of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 25, 2026.

Deborah M. Autor, Chief Policy Officer and a Director of Hims & Hers Health, Inc., sold 16,773 shares of common stock on August 18, 2026 for $27.85 per share.

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 4,938 shares of common stock on August 19, 2026 for $29.99 per share.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 25,111 shares of common stock on August 19, 2026 for $27.55 per share.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Kare Schultz, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Andrew Dudum, Chief Executive Officer, a Director and 10% owner of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 64,771 shares of common stock on June 18, 2026.

Deborah M. Autor, Chief Policy Officer and a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

David B Wells, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Irene Becklund, PAO of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Christopher D Payne, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 14, 2026.

Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., received 1,200,000 shares of common stock on August 12, 2026.

Kare Schultz, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.

Garcia Andrea G Perez, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.

Anja Manuel, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., received 260 shares of common stock on August 12, 2026.

David B Wells, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 12, 2026.

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 7,163 shares of common stock on July 17, 2026 for $31.99 per share.

Hims & Hers Health, Inc. Chief Financial Officer, Oluyemi Okupe, reported the sale of 7,163 shares of Class A Common Stock for an average price of $36.4863, executed under a pre-arranged Rule 10b5-1 trading plan.

Chief Medical Officer Patrick Harrison Carroll acquired 25,926 shares of Hims & Hers Health, Inc. through RSU vesting, with 8,310 shares withheld for taxes.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported the vesting of restricted stock units and subsequent tax-related share withholding.